Indolequinone Antitumor Agents: Reductive Activation and Elimination from (5-Methoxy-1-methyl-4,7-dioxoindol-3-yl)methyl Derivatives and Hypoxia-Selective Cytotoxicity in Vitro
- 18 June 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 41 (15) , 2720-2731
- https://doi.org/10.1021/jm970744w
Abstract
A series of indolequinones bearing a variety of leaving groups at the (indol-3-yl)methyl position was synthesized by functionalization of the corresponding 3-(hydroxymethyl)indolequinone, and the resulting compounds were evaluated in vitro as bioreductively activated cytotoxins. The elimination of a range of functional groupscarboxylate, phenol, and thiolwas demonstrated upon reductive activation under both chemical and quantitative radiolytic conditions. Only those compounds which eliminated such groups under both sets of conditions exhibited significant hypoxia selectivity, with anoxic:oxic toxicity ratios in the range 10−200. With the exception of the 3-hydroxymethyl derivative, radiolytic generation of semiquinone radicals and HPLC analysis indicated that efficient elimination of the leaving group occurred following one-electron reduction of the parent compound. The active species in leaving group elimination was predominantly the hydroquinone rather than the semiquinone radical. The resulting iminium derivative acted as an alkylating agent and was efficiently trapped by added thiol following chemical reduction and by either water or 2-propanol following radiolytic reduction. A chain reaction in the radical-initiated reduction of these indolequinones (not seen in a simpler benzoquinone) in the presence of a hydrogen donor (2-propanol) was observed. Compounds that were unsubstituted at C-2 were found to be up to 300 times more potent as cytotoxins than their 2-alkyl-substituted analogues in V79-379A cells, but with lower hypoxic cytotoxicity ratios.Keywords
This publication has 32 references indexed in Scilit:
- 2-Cyclopropylindoloquinones and Their Analogues as Bioreductively Activated Antitumor Agents: Structure−Activity in Vitro and Efficacy in VivoJournal of Medicinal Chemistry, 1997
- EO9 phase II study in advanced breast, gastric, pancreatic and colorectal carcinoma by the EORTC Early Clinical Studies GroupEuropean Journal Of Cancer, 1996
- Hypoxia-Selective Antitumor Agents. 12. Nitrobenzyl Quaternary Salts as Bioreductive Prodrugs of the Alkylating Agent MechlorethamineJournal of Medicinal Chemistry, 1996
- Reductive activation of potential antitumor mitosene compoundsJournal of Medicinal Chemistry, 1993
- Highly selective .kappa.-opioid analgesics. 2. Synthesis and structure activity relationships of novel N-(2-aminocyclohexyl)arylacetamide derivativesJournal of Medicinal Chemistry, 1989
- Characterization and chemical properties of phosphoribosylamine, an unstable intermediate in the de novo purine biosynthetic pathwayBiochemistry, 1988
- Irreversible blockage of opioid receptor types by ester homologs of .beta.-funaltrexamineJournal of Medicinal Chemistry, 1986
- Synthesis and biological activity of 6-substituted mitosene analogs of the mitomycinsJournal of Medicinal Chemistry, 1985
- Synthesis and antineoplastic activity of mitosene analogs of the mitomycinsJournal of Medicinal Chemistry, 1981
- Mitomycin antibiotics. Synthesis of 1-substituted 7-methoxymitosenesThe Journal of Organic Chemistry, 1974